BioStem Technologies, Inc.

NASDAQ:BSEM

Biotechnology

Healthcare
$3.07 -6.54%

-$0.21 today

Market cap
$52.14M
Beta
0.26
P/E (TTM)
-1.8
EPS (TTM)
-$1.63
52W Low $2.25High $8.40

Volume 0.09M

Average 0.07M

BSEM Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

BioStem Technologies, Inc.NASDAQ: BSEM

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 17.33M shares rose 3.7% year over year, ahead of the +2.5% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 2.8% from the prior quarter. Over 3 fiscal years it compounded at +13.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.7% holds above the trailing-twelve-month pace of +2.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
17.33M+2.8% QoQ
Last fiscal yearDec 2025
16.73M+2.2% YoY
LTMJun 2026
16.91M+2.5% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.7%——
1 year+2.2%——
3-year CAGR+13.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
16.73M USD
Year-over-year change
+2.2%
4-year CAGR
+9.4%

Weighted Avg Shares vs competitors

How BSEM compares with its peers on the latest reported figures

No competitor Weighted Avg Shares figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.34M6.88M16.69M301.83M47.48M
Cost of Revenue1.47M881.75K1.26M13.75M3.26M
Gross Profit2.87M5.99M15.42M287.86M44.22M
Gross Margin66.0%87.2%92.4%95.4%93.1%
Research & Development119.65K123.31K342K1.91M7.09M
Selling, General & Admin4.19M10.21M22.63M254.75M37.82M
Operating Expenses4.47M10.67M23.2M256.66M44.91M
Depreciation & Amortization283.9K243.42K229.02K293.22K219.42K
EBITDA(602K)(6.52M)(7.55M)31.49M(469.73K)
EBITDA Margin-13.9%-94.8%-45.3%10.4%-1.0%
Operating Income(1.61M)(4.68M)(7.78M)31.2M(689.15K)
Operating Margin-37.0%-68.1%-46.6%10.3%-1.5%
Interest Income0000413.85K
Interest Expense525.88K468.15K700.33K587.22K0
Other Income / Expenses193.93K(2.55M)(704.02K)(587.22K)299.5K
Income Before Tax(1.41M)(7.11M)(8.48M)30.61M(389.65K)
Pre-Tax Margin-32.5%-103.5%-50.8%10.1%-0.8%
Income Tax Expense000(1.27M)6.19M
Net Income(1.45M)(7.07M)(8.48M)31.88M(6.58M)
Net Margin-33.3%-102.9%-50.8%10.6%-13.9%
EPS (Basic)(0.12)(0.62)(0.62)1.95(0.39)
EPS (Diluted)(0.12)(0.62)(0.62)1.47(0.39)
Weighted Avg Shares11.69M11.41M13.71M16.37M16.73M
Weighted Avg Shares (Diluted)11.69M11.41M13.71M21.7M16.73M

BioStem Technologies, Inc.

NASDAQ:BSEM

Intrinsic Alpha fair value

Locked

Current Price

$3.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.